← Association for Accessible Medicines
FDANonrulemakingFDA-2018-D-1922

Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Biosimilar User Fee Act Products; Draft Guidance for Industry

RIN
—
Last modified
Jul 21, 2025
Comment window
closed 1022d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Oct 12, 2023 and Oct 12, 2023. 0 other organizations filed here. The comment window closed 1022d ago.

What Association for Accessible Medicines filed (1)

Oct 12, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2018-D-1922-0010

Association for Accessible Medicines (AAM) comments to Docket No. FDA-2018-D-1922, Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Biosimilar User Fee Act Products; Guidance for Industry

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (0)

See everyone who commented →